Burlingame, CA, United States of America

Xiaoshan Min

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Metabolic Disorder Treatments. Top assignees: Amgen Inc., Other. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoshan Min. Retrieved from https://idiyas.com/inventor/xiaoshan-min

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 11.0

ph-index = 5

Forward Citations = 70(Granted Patents)

Company Filing History:

14 out of 2,084

Amgen Inc.

patents

1 out of 834,708

Other

patents

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

Binding Proteins

Gastric Inhibitory Peptide Receptor

GLP-1 Agonists

Metabolic Disorders

ST2 Antigen

TIGIT

CD112R Blockade

Growth Differentiation Factor 15

Polypeptides

Nucleic Acid Molecules

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435149 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2025-10-07),

2. 12252540 - Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) (2025-03-18),

3. 11965029 - ST2 antigen binding proteins (2024-04-23),

4. 11919953 - TIGIT and CD112R blockade (2024-03-05),

5. 11739131 - Growth differentiation factor 15 (GDF-15) polypeptides (2023-08-29),

6. 11059895 - ST2 antigen binding proteins (2021-07-13),

7. 11046774 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2021-06-29),

8. 10894814 - Growth differentiation factor 15 (GDF-15) constructs (2021-01-19),

9. 10336798 - Growth differentiation factor 15 (GDF-15) polypeptides (2019-07-02),

10. 10294303 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2019-05-21),

11. 10227414 - ST2 antigen binding proteins (2019-03-12),

12. 9982054 - ST2 antigen binding proteins (2018-05-29),

13. 9862752 - Growth differentiation factor 15 (GDF-15) constructs (2018-01-09),

14. 9714276 - Growth differentiation factor 15 (GDF-15) polypeptides (2017-07-25),

15. 9382318 - ST2 antigen binding proteins (2016-07-05),

Title: The Innovative Journey of Xiaoshan Min

Introduction: Xiaoshan Min, a visionary inventor based in Burlingame, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Xiaoshan Min holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Xiaoshan Min has had a successful career marked by the development of cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Xiaoshan Min has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Xiaoshan Min's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true trailblazer in the world of inventions. His impact on various industries is profound, and his legacy as an inventor continues to inspire future generations of innovators.

Profile summary based on public USPTO records.